Literature DB >> 24316973

Diverting T helper cell trafficking through increased plasticity attenuates autoimmune encephalomyelitis.

Danielle Califano, Keith J Sweeney, Hung Le, Jeffrey VanValkenburgh, Eric Yager, William O'Connor, Jeffrey S Kennedy, David M Jones, Dorina Avram.   

Abstract

Naive T helper cells differentiate into functionally distinct effector subsets that drive specialized immune responses. Recent studies indicate that some of the effector subsets have plasticity. Here, we used an EAE model and found that Th17 cells deficient in the transcription factor BCL11B upregulated the Th2-associated proteins GATA3 and IL-4 without decreasing RAR-related orphan receptor γ (RORγt), IL-17, and GM-CSF levels. Surprisingly, abnormal IL-4 production affected Th17 cell trafficking, diverting migration from the draining lymph nodes/CNS route to the mesenteric lymph nodes/gut route, which ameliorated EAE without overt colitis. T helper cell rerouting in EAE was dependent on IL-4, which enhanced retinoic acid (RA) production by dendritic cells, which further induced expression of gut-homing receptors CCR9 and α4β7 on Bcl11b-deficient CD4+ T cells. Furthermore, IL-4 treatment or Th2 immunization of wild-type mice with EAE caused no alteration in Th17 cytokines or RORγt, but diverted T helper cell trafficking to the gut, which improved EAE outcome without overt colitis. Our data demonstrate that Th17 cells are permissive to Th2 gene expression without affecting Th17 gene expression. This Th17 plasticity has an impact on trafficking, which is a critical component of the immune response and may represent a possible avenue for treating multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24316973      PMCID: PMC3871236          DOI: 10.1172/JCI70103

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  56 in total

1.  Isolation of a novel family of C(2)H(2) zinc finger proteins implicated in transcriptional repression mediated by chicken ovalbumin upstream promoter transcription factor (COUP-TF) orphan nuclear receptors.

Authors:  D Avram; A Fields; K Pretty On Top; D J Nevrivy; J E Ishmael; M Leid
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

2.  Cutting edge: Identification of an alternative GATA-3 promoter directing tissue-specific gene expression in mouse and human.

Authors:  Hélène Asnagli; Maryam Afkarian; Kenneth M Murphy
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

3.  Bcl11b is required for differentiation and survival of alphabeta T lymphocytes.

Authors:  Yuichi Wakabayashi; Hisami Watanabe; Jun Inoue; Naoki Takeda; Jun Sakata; Yukio Mishima; Jiro Hitomi; Takashi Yamamoto; Masanori Utsuyama; Ohtsura Niwa; Shinichi Aizawa; Ryo Kominami
Journal:  Nat Immunol       Date:  2003-04-28       Impact factor: 25.606

4.  CCL25/CCR9 promotes the induction and function of CD103 on intestinal intraepithelial lymphocytes.

Authors:  Anna Ericsson; Marcus Svensson; Anu Arya; William W Agace
Journal:  Eur J Immunol       Date:  2004-10       Impact factor: 5.532

5.  Retinoic acid imprints gut-homing specificity on T cells.

Authors:  Makoto Iwata; Asami Hirakiyama; Yuko Eshima; Hiroyuki Kagechika; Chieko Kato; Si-Young Song
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

6.  COUP-TF (chicken ovalbumin upstream promoter transcription factor)-interacting protein 1 (CTIP1) is a sequence-specific DNA binding protein.

Authors:  Dorina Avram; Andrew Fields; Thanaset Senawong; Acharawan Topark-Ngarm; Mark Leid
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

7.  Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice.

Authors:  R Furlan; P L Poliani; P C Marconi; A Bergami; F Ruffini; L Adorini; J C Glorioso; G Comi; G Martino
Journal:  Gene Ther       Date:  2001-01       Impact factor: 5.250

8.  Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity.

Authors:  E J Kunkel; J J Campbell; G Haraldsen; J Pan; J Boisvert; A I Roberts; E C Ebert; M A Vierra; S B Goodman; M C Genovese; A J Wardlaw; H B Greenberg; C M Parker; E C Butcher; D P Andrew; W W Agace
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

9.  Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria.

Authors:  Matthew R Hepworth; Laurel A Monticelli; Thomas C Fung; Carly G K Ziegler; Stephanie Grunberg; Rohini Sinha; Adriana R Mantegazza; Hak-Ling Ma; Alison Crawford; Jill M Angelosanto; E John Wherry; Pandelakis A Koni; Frederic D Bushman; Charles O Elson; Gérard Eberl; David Artis; Gregory F Sonnenberg
Journal:  Nature       Date:  2013-05-22       Impact factor: 49.962

10.  Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis.

Authors:  Estelle Bettelli; Maria Pagany; Howard L Weiner; Christopher Linington; Raymond A Sobel; Vijay K Kuchroo
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

View more
  29 in total

1.  An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitis.

Authors:  Jonathan J Cho; Joshua M Stewart; Theodore T Drashansky; Maigan A Brusko; Ashley N Zuniga; Kyle J Lorentsen; Benjamin G Keselowsky; Dorina Avram
Journal:  Biomaterials       Date:  2017-07-24       Impact factor: 12.479

Review 2.  Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease.

Authors:  Michel DuPage; Jeffrey A Bluestone
Journal:  Nat Rev Immunol       Date:  2016-02-15       Impact factor: 53.106

Review 3.  Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer.

Authors:  Matteo Bellone; Arianna Brevi; Samuel Huber
Journal:  Microbiol Mol Biol Rev       Date:  2020-03-04       Impact factor: 11.056

Review 4.  The multifaceted roles of Bcl11b in thymic and peripheral T cells: impact on immune diseases.

Authors:  Dorina Avram; Danielle Califano
Journal:  J Immunol       Date:  2014-09-01       Impact factor: 5.422

5.  Transcription factor Bcl11b sustains iNKT1 and iNKT2 cell programs, restricts iNKT17 cell program, and governs iNKT cell survival.

Authors:  Mohammad Nizam Uddin; Dil Afroz Sultana; Kyle J Lorentsen; Jonathan J Cho; Mariana E Kirst; Mark L Brantly; Danielle Califano; Derek B Sant'Angelo; Dorina Avram
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-21       Impact factor: 11.205

6.  BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells.

Authors:  Davor Lessel; Christina Gehbauer; Nuria C Bramswig; Caroline Schluth-Bolard; Sathish Venkataramanappa; Koen L I van Gassen; Maja Hempel; Tobias B Haack; Anja Baresic; Casie A Genetti; Mariana F A Funari; Ivana Lessel; Leonie Kuhlmann; Ruth Simon; Pentao Liu; Jonas Denecke; Alma Kuechler; Ineke de Kruijff; Moneef Shoukier; Monkol Lek; Thomas Mullen; Hermann-Josef Lüdecke; Antonio M Lerario; Robin Kobbe; Thorsten Krieger; Benedicte Demeer; Marine Lebrun; Boris Keren; Caroline Nava; Julien Buratti; Alexandra Afenjar; Marwan Shinawi; Maria J Guillen Sacoto; Julie Gauthier; Fadi F Hamdan; Anne-Marie Laberge; Philippe M Campeau; Raymond J Louie; Sara S Cathey; Immo Prinz; Alexander A L Jorge; Paulien A Terhal; Boris Lenhard; Dagmar Wieczorek; Tim M Strom; Pankaj B Agrawal; Stefan Britsch; Eva Tolosa; Christian Kubisch
Journal:  Brain       Date:  2018-08-01       Impact factor: 13.501

Review 7.  Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology.

Authors:  Joseph M Cicchese; Stephanie Evans; Caitlin Hult; Louis R Joslyn; Timothy Wessler; Jess A Millar; Simeone Marino; Nicholas A Cilfone; Joshua T Mattila; Jennifer J Linderman; Denise E Kirschner
Journal:  Immunol Rev       Date:  2018-09       Impact factor: 12.988

8.  Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.

Authors:  Tayla B Heavican; Alyssa Bouska; Jiayu Yu; Waseem Lone; Catalina Amador; Qiang Gong; Weiwei Zhang; Yuping Li; Bhavana J Dave; Maarja-Liisa Nairismägi; Timothy C Greiner; Julie Vose; Dennis D Weisenburger; Cynthia Lachel; Chao Wang; Kai Fu; Jadd M Stevens; Soon Thye Lim; Choon Kiat Ong; Randy D Gascoyne; Edoardo Missiaglia; Francois Lemonnier; Corinne Haioun; Sylvia Hartmann; Martin Bjerregård Pedersen; Maria Antonella Laginestra; Ryan A Wilcox; Bin Tean Teh; Noriaki Yoshida; Koichi Ohshima; Masao Seto; Andreas Rosenwald; German Ott; Elias Campo; Lisa M Rimsza; Elaine S Jaffe; Rita M Braziel; Francesco d'Amore; Giorgio Inghirami; Francesco Bertoni; Laurence de Leval; Philippe Gaulard; Louis M Staudt; Timothy W McKeithan; Stefano Pileri; Wing C Chan; Javeed Iqbal
Journal:  Blood       Date:  2019-02-19       Impact factor: 22.113

9.  Transcription Factor Bcl11b Controls Identity and Function of Mature Type 2 Innate Lymphoid Cells.

Authors:  Danielle Califano; Jonathan J Cho; Mohammad N Uddin; Kyle J Lorentsen; Qi Yang; Avinash Bhandoola; Hongmin Li; Dorina Avram
Journal:  Immunity       Date:  2015-07-28       Impact factor: 31.745

Review 10.  Translational opportunities for targeting the Th17 axis in acute graft-vs.-host disease.

Authors:  F Malard; B Gaugler; B Lamarthee; M Mohty
Journal:  Mucosal Immunol       Date:  2016-01-27       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.